NEW YORK (GenomeWeb) – Hologic has received regulatory authorizations from the US Food and Drug Administration for two assays aimed at detecting the Zika virus.

The firm has been granted Emergency Use Authorization (EUA) for its Aptima Zika Virus assay, a transcription-mediated amplification-based test on the integrated, fully automated Hologic Panther system. The test can now be used in qualified labs on serum and plasma samples from patients meeting US Centers for Disease Control and Prevention clinical criteria.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Jun
19
Sponsored by
ACD

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.